{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:11:53Z","timestamp":1788952313649,"version":"build-2803163510"},"reference-count":84,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Resveratrol remains one of the most extensively studied plant-derived polyphenols because of its broad antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anticancer activities. However, its clinical translation has been substantially limited by its poor aqueous solubility, rapid phase II metabolism, and low systemic bioavailability, despite decades of intensive investigation. Structural modification through methoxylation has emerged as a promising strategy to overcome these pharmacokinetic limitations by enhancing metabolic stability, lipophilicity, membrane permeability, and biological activity. While considerable attention has focused on resveratrol and a limited number of established analogs, emerging methoxylated derivatives remain comparatively underexplored. This review highlights the structural characteristics, biological activities, and molecular mechanisms of two such derivatives, 4,4-(ethane-1,2-diyl)bis(2-methoxyphenol) (EG) and (Z)-3,5,4\u2032-trimethoxystilbene (Z-TMS), and discusses evidence from structurally similar, better-characterized compounds that may aid in understanding their activities. Despite promising experimental findings, the therapeutic relevance of EG and Z-TMS remains insufficiently characterized because the available evidence is predominantly derived from in vitro studies, while data on toxicity, therapeutic index, long-term safety, pharmacodynamics, and clinically relevant systemic exposure remain limited. This review emphasizes the anticancer potential of these emerging methoxylated derivatives, identifies current knowledge gaps, and provides a basis for considering them as lead compounds for anticancer drug development.<\/jats:p>","DOI":"10.3390\/ijms27188020","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:19:16Z","timestamp":1788949156000},"page":"8020","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural Modification of Resveratrol: Biological Activities and Anticancer Potential of Emerging Methoxylated Analogs"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0493-4908","authenticated-orcid":false,"given":"Yashvi","family":"Sethia","sequence":"first","affiliation":[{"name":"Students\u2019 Scientific Club at Department of Human Immunology, Faculty of Medicine, College for Medical Sciences, University of Rzesz\u00f3w, 35-959 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Kopera","sequence":"additional","affiliation":[{"name":"Department of Human Immunology, Faculty of Medicine, College for Medical Sciences, University of Rzesz\u00f3w, 35-959 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1264-2882","authenticated-orcid":false,"given":"Jacek","family":"Tabarkiewicz","sequence":"additional","affiliation":[{"name":"Department of Human Immunology, Faculty of Medicine, College for Medical Sciences, University of Rzesz\u00f3w, 35-959 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","article-title":"Resveratrol for cancer therapy: Challenges and future perspectives","volume":"515","author":"Ren","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/nyas.12798","article-title":"Resveratrol, in its natural combination in whole grape, for health promotion and disease management","volume":"1348","author":"Singh","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_3","first-page":"12","article-title":"Resveratrol: An active natural compound in red wines for health","volume":"21","author":"Murtaza","year":"2013","journal-title":"J. Food Drug Anal."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41698-017-0038-6","article-title":"The therapeutic potential of resveratrol: A review of clinical trials","volume":"1","author":"Berman","year":"2017","journal-title":"npj Precis. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Pe\u00f1alva, R., Morales, J., Gonz\u00e1lez-Navarro, C.J., Larra\u00f1eta, E., Quincoces, G., Pe\u00f1uelas, I., and Irache, J.M. (2018). Increased Oral Bioavailability of Resveratrol by Its Encapsulation in Casein Nanoparticles. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092816"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.2010.05842.x","article-title":"Bioavailability of resveratrol","volume":"1215","author":"Walle","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1158\/0008-5472.CAN-10-2027","article-title":"Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients","volume":"70","author":"Patel","year":"2010","journal-title":"Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2337\/db12-0975","article-title":"High-dose resveratrol supplementation in obese men: An investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition","volume":"62","author":"Poulsen","year":"2013","journal-title":"Diabetes"},{"key":"ref_9","unstructured":"National Center for Biotechnology Information (2026, August 01). PubChem Compound Summary for CID 14803825, 4, 4\u2032-(Ethane-1,2-diyl)bis(2-methoxyphenol), Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/14803825."},{"key":"ref_10","unstructured":"National Center for Biotechnology Information (2026, June 25). PubChem Compound Summary for CID 9878556, (Z)-3,5,4\u2032-Trimethoxystilbene, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Z_-3_5_4_-Trimethoxystilbene."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Yu, X., Chen, M., Wu, J., and Song, R. (2024). Research progress of SIRTs activator resveratrol and its derivatives in autoimmune diseases. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1390907"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Chimento, A., De Amicis, F., Sirianni, R., Sinicropi, M.S., Puoci, F., Casaburi, I., Saturnino, C., and Pezzi, V. (2019). Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061381"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Innets, B., Thongsom, S., Petsri, K., Racha, S., Yokoya, M., Moriue, S., Chaotham, C., and Chanvorachote, P. (2022). Akt\/mTOR Targeting Activity of Resveratrol Derivatives in Non-Small Lung Cancer. Molecules, 27.","DOI":"10.3390\/molecules27238268"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11010-020-03837-0","article-title":"Effect of methoxy stilbenes-analogs of resveratrol-on the viability and induction of cell cycle arrest and apoptosis in human myeloid leukemia cells","volume":"474","author":"Kaczmarek","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ijc.11344","article-title":"Resveratrol analog (Z)-3,5,4\u2032-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization","volume":"107","author":"Schneider","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_16","unstructured":"National Center for Biotechnology Information (2026, June 25). PubChem Compound Summary for CID 3085362, 5-(2-(3-Hydroxy-5-methoxyphenyl)ethyl)-2-methoxyphenol, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Gigantol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tiv.2017.06.004","article-title":"The effect of resveratrol, its naturally occurring derivatives and tannic acid on the induction of cell cycle arrest and apoptosis in rat C6 and human T98G glioma cell lines","volume":"43","author":"Kaczmarek","year":"2017","journal-title":"Toxicol. Vitr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s13197-013-0993-z","article-title":"Resveratrol content and antioxidant properties of underutilized fruits","volume":"52","author":"Shrikanta","year":"2015","journal-title":"J. Food Sci. Technol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","article-title":"Therapeutic potential of resveratrol: The in vivo evidence","volume":"5","author":"Baur","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kursvietiene, L., Kopustinskiene, D.M., Staneviciene, I., Mongirdiene, A., Kubov\u00e1, K., Masteikova, R., and Bernatoniene, J. (2023). Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions. Antioxidants, 12.","DOI":"10.3390\/antiox12122056"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"114962","DOI":"10.1016\/j.taap.2020.114962","article-title":"Comparative toxicokinetics of Trans-resveratrol and its major metabolites in Harlan Sprague Dawley rats and B6C3F1\/N mice following oral and intravenous administration","volume":"394","author":"Mutlu","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1124\/dmd.104.000885","article-title":"High absorption but very low bioavailability of oral resveratrol in humans","volume":"32","author":"Walle","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/jpet.102.033340","article-title":"Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model","volume":"302","author":"Marier","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/CMAR.S4544","article-title":"Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer","volume":"1","author":"Holcombe","year":"2009","journal-title":"Cancer Manag. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12935-019-0906-y","article-title":"Resveratrol is a promising agent for colorectal cancer prevention and treatment: Focus on molecular mechanisms","volume":"19","author":"Honari","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1158\/1940-6207.CAPR-11-0148","article-title":"Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics","volume":"4","author":"Howells","year":"2011","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cmet.2011.10.002","article-title":"Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans","volume":"14","author":"Timmers","year":"2011","journal-title":"Cell Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/pros.23006","article-title":"Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men","volume":"75","author":"Kjaer","year":"2015","journal-title":"Prostate"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjh.12154","article-title":"A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma","volume":"160","author":"Popat","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/01635581.2012.654926","article-title":"Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer","volume":"64","author":"Zhu","year":"2012","journal-title":"Nutr. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"van der Made, S.M., Plat, J., and Mensink, R.P. (2015). Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: A randomized, placebo-controlled crossover trial. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0118393"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10557-012-6427-8","article-title":"Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: A triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease","volume":"27","author":"Larrosa","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1536\/ihj.16-373","article-title":"Resveratrol Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes Mellitus","volume":"58","author":"Imamura","year":"2017","journal-title":"Int. Heart J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41387-018-0059-4","article-title":"Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial","volume":"8","author":"Bo","year":"2018","journal-title":"Nutr. Diabetes"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0779-0","article-title":"Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer\u2019s disease","volume":"14","author":"Moussa","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/nyas.13431","article-title":"Resveratrol for Alzheimer\u2019s disease","volume":"1403","author":"Sawda","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"10978","DOI":"10.1038\/s41598-022-13920-9","article-title":"Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19)","volume":"12","author":"McCreary","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"298ra117","DOI":"10.1126\/scitranslmed.aaa7619","article-title":"Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice","volume":"7","author":"Cai","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"de Vries, K., Strydom, M., and Steenkamp, V. (2021). A Brief Updated Review of Advances to Enhance Resveratrol\u2019s Bioavailability. Molecules, 26.","DOI":"10.3390\/molecules26144367"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1158\/1055-9965.EPI-07-0022","article-title":"Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent","volume":"16","author":"Boocock","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kang, S.-Y., Lee, J.K., Choi, O., Kim, C.Y., Jang, J.-H., Hwang, B.Y., and Hong, Y.-S. (2014). Biosynthesis of methylated resveratrol analogs through the construction of an artificial biosynthetic pathway in, E. coli. BMC Biotechnol., 14.","DOI":"10.1186\/1472-6750-14-67"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/biof.1410","article-title":"Metabolism and pharmacokinetics of resveratrol and pterostilbene","volume":"44","author":"Wang","year":"2018","journal-title":"Biofactors"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Fragopoulou, E., Gkotsi, K., Petsini, F., Gioti, K., Kalampaliki, A.D., Lambrinidis, G., Kostakis, I.K., and Tenta, R. (2023). Synthesis and Biological Evaluation of Resveratrol Methoxy Derivatives. Molecules, 28.","DOI":"10.3390\/molecules28145547"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00280-010-1525-4","article-title":"Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats","volume":"68","author":"Kapetanovic","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1158\/0008-5472.CAN-15-2722","article-title":"(Z)-3,5,4\u2032-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression","volume":"76","author":"Nguyen","year":"2016","journal-title":"Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Harvey, B., Wright, M.E., Guenthner, A., Compel, S., Davis, M.C., Lamison, K.R., Cambrea, L., Meylemans, H.A., Mccormick, S., and Groshens, T. (2011). Cyanate Ester Composite Resins Derived from Renewable Polyphenol Sources, Iowa State University. DTIC Accession No. ADA557386.","DOI":"10.21236\/ADA557386"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1039\/D4MA00610K","article-title":"Fire-resistant propargyl ether networks derived from bio-based hydroxycinnamic acids","volume":"5","author":"Zavala","year":"2024","journal-title":"Mater. Adv."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1021\/acs.energyfuels.6b02250","article-title":"Production of high-yield bio-oil with a high effective hydrogen\/carbon molar ratio through acidolysis and in situ hydrogenation","volume":"30","author":"Huang","year":"2016","journal-title":"Energy Fuels"},{"key":"ref_49","first-page":"6181","article-title":"Anti-mitotic properties of resveratrol analog (Z)-3,5,4\u2032-trimethoxystilbene","volume":"16","author":"Chabert","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpba.2010.03.028","article-title":"Determination of Z-3,5,4\u2032-trimethoxystilbene in rat plasma by a simple HPLC method: Application in a pre-clinical pharmacokinetic study","volume":"53","author":"Lin","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_51","first-page":"3019","article-title":"Kinetic radical scavenging activity and cytotoxicity of 2-methoxy- and 2-t-butyl-substituted phenols and their dimers","volume":"24","author":"Fujisawa","year":"2004","journal-title":"Anticancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1021\/jo0342931","article-title":"Antioxidant activity of o-bisphenols: The role of intramolecular hydrogen bonding","volume":"68","author":"Amorati","year":"2003","journal-title":"J. Org. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Scrima, M., De Marco, C., Fabiani, F., Franco, R., Pirozzi, G., Rocco, G., Ravo, M., Weisz, A., Zoppoli, P., and Ceccarelli, M. (2012). Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): New insights on the role of phosphatydil-inositol-3 kinase. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030427"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1016\/j.ejmech.2010.03.024","article-title":"Structural determinants of resveratrol for cell proliferation inhibition potency: Experimental and docking studies of new analogs","volume":"45","author":"Colin","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.0.CO;2-U","article-title":"Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle","volume":"18","author":"Jordan","year":"1998","journal-title":"Med. Res. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: A changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ng.2481","article-title":"Dclk1 distinguishes between tumor and normal stem cells in the intestine","volume":"45","author":"Nakanishi","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/21541248.2016.1208792","article-title":"Functional implication of Dclk1 and Dclk1-expressing cells in cancer","volume":"8","author":"Westphalen","year":"2017","journal-title":"Small GTPases"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1381612824666180123110042","article-title":"Colchicine Pharmacokinetics and Mechanism of Action","volume":"24","author":"Angelidis","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1582-4934.2003.tb00210.x","article-title":"Polyamine metabolism and cancer","volume":"7","author":"Thomas","year":"2003","journal-title":"J. Cell. Mol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd2243","article-title":"Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases","volume":"6","author":"Casero","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrc1454","article-title":"Polyamines and cancer: Old molecules, new understanding","volume":"4","author":"Gerner","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2455539","DOI":"10.1080\/07853890.2025.2455539","article-title":"Risk factors for hepatocellular carcinoma: An umbrella review of systematic review and meta-analysis","volume":"57","author":"Wang","year":"2025","journal-title":"Ann. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"120595","DOI":"10.1016\/j.jep.2025.120595","article-title":"Gigantol: A principal bioactive constituent of Dendrobium species-multi-target mechanisms, network pharmacology, and therapeutic perspectives","volume":"355","author":"Shi","year":"2026","journal-title":"J. Ethnopharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.56808\/3027-7922.1973","article-title":"Gigantol-induced apoptosis in lung cancer cell through mitochondrial-dependent pathway","volume":"38","author":"Charoenrungruang","year":"2014","journal-title":"Thai J. Pharm. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Losuwannarak, N., Maiuthed, A., Kitkumthorn, N., Leelahavanichkul, A., Roytrakul, S., and Chanvorachote, P. (2019). Gigantol Targets Cancer Stem Cells and Destabilizes Tumors via the Suppression of the PI3K\/AKT and JAK\/STAT Pathways in Ectopic Lung Cancer Xenografts. Cancers, 11.","DOI":"10.3390\/cancers11122032"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"781","DOI":"10.21873\/cgp.20232","article-title":"Gigantol Targets MYC for Ubiquitin-proteasomal Degradation and Suppresses Lung Cancer Cell Growth","volume":"17","author":"Losuwannarak","year":"2020","journal-title":"Cancer Genom. Proteom."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3892\/or.2016.5299","article-title":"Gigantol attenuates the proliferation of human liver cancer HepG2 cells through the PI3K\/Akt\/NF-\u03baB signaling pathway","volume":"37","author":"Chen","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e22944","DOI":"10.1002\/jbt.22944","article-title":"Gigantol inhibits proliferation and enhanced oxidative stress-mediated apoptosis through modulating of Wnt\/\u03b2-catenin signaling pathway in HeLa cells","volume":"36","author":"Kang","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"119354","DOI":"10.1016\/j.lfs.2021.119354","article-title":"Gigantol inhibits proliferation and enhances DDP-induced apoptosis in breast-cancer cells by downregulating the PI3K\/Akt\/mTOR signaling pathway","volume":"274","author":"Huang","year":"2021","journal-title":"Life Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"11337","DOI":"10.2147\/OTT.S271032","article-title":"Gigantol Attenuates the Metastasis of Human Bladder Cancer Cells, Possibly Through Wnt\/EMT Signaling","volume":"13","author":"Zhao","year":"2020","journal-title":"Onco Targets Ther."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Chowdhury, R., Al-Qaaneh, A.M., Bhuia, S., Al-Azzawi, M.A., Rakib, A.I., El-Shazly, M., Islam, T., and El-Nashar, H.A.S. (2025). A comprehensive review about the anticancer properties of gigantol. Nat. Prod. Res., 1\u201316.","DOI":"10.1080\/14786419.2025.2600500"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/znc-2007-3-406","article-title":"Antiproliferative activity of methylated analogues of E- and Z-resveratrol","volume":"62","author":"Cardile","year":"2007","journal-title":"Z. Naturforsch C J. Biosci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"155436","DOI":"10.1016\/j.phymed.2024.155436","article-title":"Trans-3, 5, 4\u2032-trimethoxystilbene restrains non-small-cell lung carcinoma progression via suppressing M2 polarization through inhibition of m6A modified circPACRGL-mediated Hippo signaling","volume":"126","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.taap.2013.07.019","article-title":"3,5,4\u2032-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K\/Akt and Wnt\/\u03b2-catenin signaling cascades and reversal of epithelial-mesenchymal transition","volume":"272","author":"Tsai","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mnfr.200800123","article-title":"Resveratrol analog-3,5,4\u2032-trimethoxy-trans-stilbene inhibits invasion of human lung adenocarcinoma cells by suppressing the MAPK pathway and decreasing matrix metalloproteinase-2 expression","volume":"53","author":"Yang","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/jcmm.14086","article-title":"Trans-3,5,4\u2032-trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK\/Akt\/Bcl-2 pathway by upregulation of miR-345 and miR-498","volume":"23","author":"Lu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/mc.20352","article-title":"Antitumor activity of 3,5,4\u2032-trimethoxystilbene in COLO 205 cells and xenografts in SCID mice","volume":"47","author":"Pan","year":"2008","journal-title":"Mol. Carcinog."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jcb.22405","article-title":"Resveratrol derivative, trans-3,5,4\u2032-trimethoxystilbene, exerts antiangiogenic and vascular-disrupting effects in zebrafish through the downregulation of VEGFR2 and cell-cycle modulation","volume":"109","author":"Alex","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4161\/oxim.2.5.9498","article-title":"Plant polyphenols as dietary antioxidants in human health and disease","volume":"2","author":"Pandey","year":"2009","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/nu2111106","article-title":"Polyphenols and human health: Prevention of disease and mechanisms of action","volume":"2","author":"Vauzour","year":"2010","journal-title":"Nutrients"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/1568026620666200303123102","article-title":"Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors","volume":"20","author":"Sabbah","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8020\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:21:44Z","timestamp":1788949304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":84,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27188020"],"URL":"https:\/\/doi.org\/10.3390\/ijms27188020","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]}}}